Reprogramming camp for immune cells shows early promise for autoimmune diseases
Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune…
Doctors warn major changes coming for weight loss drugs in Mass.
Patients and doctors are bracing as some major insurers get ready to roll out changes to coverage for…
The 18 Most Promising Startups in Healthcare of 2025, According to VCs
Nominated by: Blake Wu, NEA (an investor) Total funding: $101 million, according to the company. What it does:…
Can AI developers avoid Frankenstein’s fateful mistake?
Audiences already know the story of Frankenstein. The gothic novel — adapted dozens of times, most recently in…
Common opioid is not that effective for easing chronic pain, study finds
Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new…
Knowing patient’s genetic make-up may change the way medicines are prescribed
SINGAPORE – Not all medicines work the same way on every patient, and part of the answer lies…
Why it’s ‘a very exciting time’ for dementia researchers
Like a lot of people my age, there are times when I can’t find my keys, or my…
Why schizophrenia may be ‘the most devastating of mental illnesses’
For Henry Cockburn, the onset of schizophrenia felt like pure common sense.It was February 2002, and the 20-year-old…
Prevent Muscle Loss on GLP-1 Weight Loss Medications
With more than 15 million Americans taking GLP-1 medications like Ozempic, Wegovy and Mounjaro, experts say patients could…
Expanding Patient Pool, FDA Approvals, And Robust Pipeline Fuel Growth To 2034 Delveinsight
(MENAFN– GetNews) “GLP-1 Agonists Market Size, Target Population, Competitive Landscape & Market Forecast – 2034″DelveInsight’s report projects strong…
AI, ChatGPT Psychosis Explained by Psychiatrist Whose Patients Had It
This as-told-to essay is based on a conversation with Dr. Keith Sakata, a psychiatrist working at UCSF in…